Taylor Jennifer H 4
4 · Freshworks Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Freshworks (FRSH) Director Jennifer Taylor Receives Award; Sells Shares
What Happened
- Jennifer H. Taylor, a director of Freshworks, received a grant of 22,299 shares on 2026-07-01 (recorded at $0 cash cost on the Form 4) and sold 6,618 shares on 2026-07-02 for a weighted average price of $10.44, totaling approximately $69,092.
- The 22,299-share grant consisted of 1,046 fully-vested restricted shares issued in lieu of cash director compensation and 21,253 RSUs that vest in full on July 1, 2027 (see footnotes). The sale was effected under a pre-established Rule 10b5-1 trading plan.
Key Details
- Transaction dates: Award on 2026-07-01; Sale on 2026-07-02.
- Sale price/details: Weighted average $10.44; sales executed at prices between $10.33 and $10.53 per share. Total proceeds ≈ $69,092.
- Grant breakdown: 1,046 fully vested restricted shares in lieu of cash (Q2 2026 director comp); 21,253 RSUs vesting 7/1/2027. Grant amounts were calculated using the 30-day average closing price before 7/1/2026.
- Sales plan: Disposition executed pursuant to a Rule 10b5-1 trading plan adopted March 20, 2026.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Filing timeliness: Reported period 2026-07-01 and filed 2026-07-02—appears timely (no late filing indicated).
Context
- The award is compensation: RSUs are a contingent right to receive shares at settlement (vesting 7/1/2027), while the small block of vested shares was taken instead of cash pay. Such grants are routine director compensation.
- The sale under a 10b5-1 plan indicates the disposition was pre-planned and not necessarily a real-time signal about the director’s view of the company. The cash proceeds (~$69k) are modest relative to many insider transactions.
Insider Transaction Report
Form 4
Freshworks Inc.FRSH
Taylor Jennifer H
Director
Transactions
- Award
Class A Common Stock
[F1][F2]2026-07-01+22,299→ 69,291 total - Sale
Class A Common Stock
[F3][F4]2026-07-02$10.44/sh−6,618$69,092→ 62,673 total
Footnotes (4)
- [F1]With respect to 1,046 shares, represents the grant of fully-vested restricted stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's Non-Employee Director Compensation Policy. Grant reflects director compensation for the second quarter of 2026. The number of shares received in lieu of cash was calculated by dividing the applicable value of the equity by the average closing price of our common stock over the 30 consecutive trading days immediately preceding July 1, 2026, rounded down to the nearest whole share.
- [F2]With respect to 21,253 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy. Each of these RSUs represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The number of RSUs granted was calculated by dividing the applicable value of the equity by the average closing price of our common stock over the 30 consecutive trading days immediately preceding July 1, 2026, rounded down to the nearest whole share. The shares shall vest in full on July 1, 2027; provided, however, that in the event a director is up for re-election at the Issuer's next annual meeting of stockholders and is not elected to continue serving as a member of the board of directors at such annual meeting of stockholders, the shares shall be deemed fully vested on that annual meeting date.
- [F3]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted March 20, 2026.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.33 to $10.53 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
Signature
/s/ Pamela Sergeeff, Attorney-in-Fact|2026-07-02